News | February 16, 2024
Glenmark Pharma posts Q3 FY24 net loss of Rs. 331 Cr
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
iSolveSM information on demand is the result of our focus on customer relationship
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
The 200 bedded hospital owned & operated by Alexis
Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges
KIMS has reported total income of Rs. 609.091 crores during the period ended December 31, 2023
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
Tritan Renew, which is made with 50% certified recycled content derived from hard-to-recycle waste, performs like virgin-quality material
Gabapentin is indicated for the management of Postherpetic Neuraligia
Subscribe To Our Newsletter & Stay Updated
